Complementary and Alternative Medicine for Idiopathic Parkinson's Disease: An Evidence-Based Clinical Practice Guideline.

Author: Cho KH1, Kim TH2, Kwon S1, Jung WS1, Moon SK1, Ko CN1,3, Cho SY1,3, Jeon CY4, Lee SH5, Choi TY6, Jun JH6, Choi J7, Lee MS6, Chung EK8
1Department of Cardiology and Neurology, College of Korean Medicine, Kyung Hee University, Seoul, South Korea.
2Korean Medicine Clinical Trial Center, Korean Medicine Hospital, Kyung Hee University, Seoul, South Korea.
3Stroke and Neurological Disorders Center, Kyung Hee University Hospital at Gangdong, Seoul, South Korea.
4Department of Korean Internal Medicine, College of Korean Medicine, Gachon University, Seongnam, South Korea.
5Gangdong Mokhuri Oriental Medical Hospital, Seoul, South Korea.
6Clinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon, South Korea.
7Integrative Health Promotion Team, Korea Health Promotion Institute, Seoul, South Korea.
8Division of Clinical Pharmacy, Department of Pharmacy, College of Pharmacy, Kyung Hee University, Seoul, South Korea.
Conference/Journal: Front Aging Neurosci.
Date published: 2018 Oct 15
Other: Volume ID: 10 , Pages: 323 , Special Notes: doi: 10.3389/fnagi.2018.00323. eCollection 2018. , Word Count: 122

Patients with idiopathic Parkinson's disease (IPD) require long-term care and are reported to use complementary and alternative medicine (CAM) interventions frequently. This CAM-specific clinical practice guideline (CPG) makes recommendations for the use of CAM, including herbal medicines, acupuncture, moxibustion, pharmaco-acupuncture, and qigong (with Tai chi) in patients with IPD. This guideline was developed using an evidence-based approach with randomized controlled trials currently available. Even though this CPG had some limitations, mainly originating from the bias inherent in the research on which it is based, it would be helpful when assessing the value of the CAM interventions frequently used in patients with IPD.

KEYWORDS: clinical practice guideline; complementary and alternative medicine; evidence-based medicine; idiopathic Parkinson’s disease; recommendations

PMID: 30374299 PMCID: PMC6196228 DOI: 10.3389/fnagi.2018.00323